Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Crohn's Disease, Active”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05394805
What this trial is testing

Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie 156
Not applicableStudy completedNCT00524537
What this trial is testing

A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie (prior sponsor, Abbott) 5,025
Not applicableLooking for participantsNCT05321745
What this trial is testing

Fecal Microbiota Transplantation in Pediatric Crohn's Disease

Who this might be right for
Crohn Disease
Biao Zou 40
Not applicableActive Not RecruitingNCT07484620
What this trial is testing

Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease

Who this might be right for
Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)Inflamatory Bowel Disease
Universidad Complutense de Madrid 100
Not applicableUnknownNCT03325582
What this trial is testing

MR Assessment of Perianal Crohn's Disease

Who this might be right for
Perianal Fistula
University of Nottingham 25
Large-scale testing (Phase 3)Study completedNCT02394028
What this trial is testing

Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Hoffmann-La Roche 1,035
Not applicableLooking for participantsNCT06023030
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

Who this might be right for
Crohn's Disease
AbbVie 240
Not applicableUnknownNCT04467580
What this trial is testing

Development of Inflammation and Fibrosis Index, Combining MRI and PET 18F-FDG, in Patient's With Crohn's Disease

Who this might be right for
Crohn Disease
Central Hospital, Nancy, France 59
Large-scale testing (Phase 3)WithdrawnNCT03905109
What this trial is testing

Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients

Who this might be right for
Crohn Disease
Abivax S.A.
Testing effectiveness (Phase 2)Study completedNCT00055367
What this trial is testing

Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Biogen 30
Testing effectiveness (Phase 2)Study completedNCT02330653
What this trial is testing

Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis

Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
Stacy A. Kahn 15
Testing effectiveness (Phase 2)Ended earlyNCT00899678
What this trial is testing

The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents

Who this might be right for
Crohn's Disease
UCB Celltech 99
Large-scale testing (Phase 3)Ended earlyNCT01562951
What this trial is testing

Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants

Who this might be right for
Crohn's DiseaseMucosal Inflammation
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 15
Testing effectiveness (Phase 2)Study completedNCT00106314
What this trial is testing

An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease

Who this might be right for
Crohn's Disease
Inflabloc Pharmaceuticals 75
Not applicableLooking for participantsNCT07621783
What this trial is testing

Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context

Who this might be right for
Crohn Disease (CD)Ulcerative Colitis (UC)
Imelda GI Clinical Research Center 100
Testing effectiveness (Phase 2)Study completedNCT02976129
What this trial is testing

A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease

Who this might be right for
Crohn's Disease
VHsquared Ltd. 125
Testing effectiveness (Phase 2)Ended earlyNCT00206700
What this trial is testing

Open-label Trial of Leukine in Active Crohn's Disease

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 378
Large-scale testing (Phase 3)Active Not RecruitingNCT03466411
What this trial is testing

The Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 1,409
Not applicableStudy completedNCT02750800
What this trial is testing

Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis+3 more
AbbVie 427
Testing effectiveness (Phase 2)Study completedNCT00102921
What this trial is testing

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Amgen 70
Next Page